FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

372547000: Brimonidine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1197840016 Brimonidine (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1211078016 Brimonidine en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Brimonidine Is a Substance with alpha-2 adrenergic receptor agonist mechanism of action true Inferred relationship Existential restriction modifier
Brimonidine Is a Anti glaucoma agent false Inferred relationship Existential restriction modifier
Brimonidine Is a Imidazole true Inferred relationship Existential restriction modifier
Brimonidine Is a Quinoxaline true Inferred relationship Existential restriction modifier
Brimonidine Has disposition Alpha-2 adrenergic receptor agonist true Inferred relationship Existential restriction modifier
Brimonidine Is a Substance with adrenergic receptor agonist mechanism of action false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing brimonidine Has active ingredient True Brimonidine Inferred relationship Existential restriction modifier 1
Brimonidine tartrate Is a False Brimonidine Inferred relationship Existential restriction modifier
Product containing brimonidine and timolol Has active ingredient True Brimonidine Inferred relationship Existential restriction modifier 1
Brimonidine 0.2%/timolol 0.5% eye drops Has active ingredient False Brimonidine Inferred relationship Existential restriction modifier
Brimonidine tartrate Is modification of True Brimonidine Inferred relationship Existential restriction modifier
Product containing brimonidine in ocular dose form (medicinal product form) Has active ingredient True Brimonidine Inferred relationship Existential restriction modifier 1
Brimonidine Has active ingredient True Brimonidine Inferred relationship Existential restriction modifier 1
Brimonidine + Timolol Has active ingredient True Brimonidine Inferred relationship Existential restriction modifier 1
Product containing only brimonidine in ocular dose form (medicinal product form) Has active ingredient True Brimonidine Inferred relationship Existential restriction modifier 1
Product containing brimonidine and timolol in ocular dose form (medicinal product form) Has active ingredient True Brimonidine Inferred relationship Existential restriction modifier 1
Product containing only brimonidine and timolol in ocular dose form (medicinal product form) Has active ingredient True Brimonidine Inferred relationship Existential restriction modifier 1
Product containing precisely brimonidine tartrate 2 milligram/1 milliliter conventional release eye drops Has active ingredient False Brimonidine Inferred relationship Existential restriction modifier
Timolol 5mg/ml / Brimonidine 2mg/ml eye drops Has active ingredient False Brimonidine Inferred relationship Existential restriction modifier
Combigan eye drops (AbbVie Ltd) Has active ingredient True Brimonidine Inferred relationship Existential restriction modifier
Combigan eye drops (Waymade Healthcare Plc) Has active ingredient True Brimonidine Inferred relationship Existential restriction modifier
Combigan eye drops (Mawdsley-Brooks & Company Ltd) Has active ingredient True Brimonidine Inferred relationship Existential restriction modifier
Combigan eye drops (Doncaster Pharmaceuticals Ltd) Has active ingredient True Brimonidine Inferred relationship Existential restriction modifier
Combigan eye drops (Lexon (UK) Ltd) Has active ingredient True Brimonidine Inferred relationship Existential restriction modifier
Generic Mirvaso gel Has active ingredient False Brimonidine Inferred relationship Existential restriction modifier
Mirvaso 3mg/g gel (Galderma (UK) Ltd) Has active ingredient True Brimonidine Inferred relationship Existential restriction modifier
Generic Mirvaso gel Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Brimonidine Inferred relationship Existential restriction modifier
Generic Mirvaso gel 30 gram Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Brimonidine Inferred relationship Existential restriction modifier
Mirvaso 3mg/g gel (Galderma (UK) Ltd) 30 gram Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Brimonidine Inferred relationship Existential restriction modifier
Mirvaso 3mg/g gel (Galderma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Brimonidine Inferred relationship Existential restriction modifier
Brinzolamide + Brimonidine Has active ingredient True Brimonidine Inferred relationship Existential restriction modifier
Brinzolamide 10mg/ml / Brimonidine 2mg/ml eye drops Has active ingredient True Brimonidine Inferred relationship Existential restriction modifier
Simbrinza 10mg/ml / 2mg/ml suspension eye drops (Alcon Laboratories (UK) Ltd) Has active ingredient True Brimonidine Inferred relationship Existential restriction modifier
Generic Mirvaso gel Has basis of strength substance False Brimonidine Inferred relationship Existential restriction modifier
Generic Mirvaso gel 30 gram Has basis of strength substance True Brimonidine Inferred relationship Existential restriction modifier
Mirvaso 3mg/g gel (Galderma (UK) Ltd) 30 gram Has basis of strength substance True Brimonidine Inferred relationship Existential restriction modifier
Mirvaso 3mg/g gel (Galderma (UK) Ltd) Has basis of strength substance True Brimonidine Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start